Bausch Health Reports Strong Q2 Growth, Raises Guidance

Bausch Health Companies (TSE:BHC) has released an update.

Bausch Health Companies Inc. has reported a robust second quarter in 2024 with consolidated revenues increasing by 11% to $2.40 billion, and an organic growth of 8%. The company also saw a rise in adjusted EBITDA by 10% and has raised its full-year revenue and adjusted EBITDA guidance, indicating strong financial health and growth.

For further insights into TSE:BHC stock, check out TipRanks’ Stock Analysis page.